VEA
COGT icon

Virtus ETF Advisers’s Cogent Biosciences COGT Stock Holding History

Virtus ETF Advisers’s Portfolio COGT Stock Details COGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-8,524
Closed -$66.5K – 507
2024
Q4 		$66.5K Sell
8,524
-1,742
-17% -$17.4K 0.03% 408
2024
Q3 		$111K Buy
10,266
+185
+2% +$1.8K 0.05% 361
2024
Q2 		$85K Sell
10,081
-7,386
-42% -$56K 0.04% 382
2024
Q1 		$117K Sell
17,467
-1,199
-6% -$7.41K 0.06% 348
2023
Q4 		$110K Buy
18,666
+10,966
+142% +$84K 0.07% 330
2023
Q3 		$75.1K Sell
7,700
-762
-9% -$9.04K 0.05% 373
2023
Q2 		$100K Buy
8,462
+95
+1% +$1.09K 0.06% 380
2023
Q1 		$90.3K Sell
8,367
-3,209
-28% -$41K 0.05% 364
2022
Q4 		$134K Buy
+11,576
New +$143K 0.07% 383
2022
Q2 		– Sell
-19,452
Closed -$146K – 448
2022
Q1 		$146K Sell
19,452
-1,158
-6% -$8.06K 0.07% 228
2021
Q4 		$177K Sell
20,610
-2,725
-12% -$23.7K 0.07% 256
2021
Q3 		$196K Sell
23,335
-1,219
-5% -$9.34K 0.09% 274
2021
Q2 		$199K Sell
24,554
-3,547
-13% -$30K 0.08% 351
2021
Q1 		$247K Buy
+28,101
New +$271K 0.1% 292

Other funds holding COGT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Virtus ETF Advisers's COGT Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Cogent Biosciences (COGT) in Q1 2025, closing a stake of 8,524 shares — an estimated $66.5K sold.

Virtus ETF Advisers first reported a position in COGT in Q1 2021 and held it in 14 quarters. The position peaked at $247K in Q1 2021. 186 funds tracked by Wall St. Rank hold COGT as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Cogent Biosciences position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 8,524 Cogent Biosciences shares in Q1 2025, an estimated $66.5K.
  • Virtus ETF Advisers first reported a position in Cogent Biosciences in Q1 2021 and held it in 14 quarters.
  • Virtus ETF Advisers's Cogent Biosciences position peaked at $247K in Q1 2021.
  • 186 funds tracked by Wall St. Rank held Cogent Biosciences as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.